R. Bhalavat

Brachytherapy Technology and Principles

A Mehta, Raghavendra Hajare, R. Bhalavat, Shyam Shrivastava et autres

in, us (code pays fourni par la source)

Fatigue in patients with head-and-neck malignancies receiving radiation therapy and impact on quality of life: A prospective observational study

Z. Moosa, Ankita Kapoor, M. Chandra, R. Bhalavat et autres

ABSTRACT Background: Cancer-related fatigue is an important but often unrecognized problem in patients with head-and-neck cancer undergoing radiation therapy. Objectives: To assess cancer-related fatigue in patients with head-and-neck cancer undergoing radiation therapy, and to evaluate for any impact on the quality of …

Pediatric extremity rhabdomyosarcoma treated with re-brachytherapy in recurrent setting

Ankita Rungta Kapoor, Manish Chandra, R. Bhalavat, Chetna Bakshi et autres

Rhabdomyosarcomas (RMS) are pediatric soft-tissue sarcomas arising from immature mesenchymal cells that are intended to form striated skeletal muscles. Brachytherapy delivers high-dose of precised radiation to the target tissue with high conformity, sparing the nearby normal tissues, hence allowing dose escalation and …

us (code pays fourni par la source)

Qualitative and dosimetric assessment of radiation-induced xerostomia in patients with oral cancers treated with 3DCRT versus IMRT

N. Vishnu Swaroop Reddy, Ankita Rungta Kapoor, R. Bhalavat, Manish Chandra et autres

Background: Xerostomia is an important complication in patients with head-and-neck cancer treated with radiotherapy. It is caused by the radiation dose to the salivary glands situated in the lateral facial and submandibular regions, which are commonly included in or are close to …

Hippocampal avoidance in WBRT for metastases: comparative neurocognitive and dosimetric assessment

Vibhay Pareek, Manish Chandra, R. Bhalavat, K. George et autres

in (code pays fourni par la source)

Clinical Outcomes and Toxicity Profile With IMRT or Brachytherapy Boost in Oropharyngeal Malignancies: A Randomized, Open Label Study

Vibhay Pareek, R. Bhalavat, M. Chandra, L. Nellore et autres

in (code pays fourni par la source)

OC-0023 IMRT or Brachytherapy boost in oropharyngeal malignancies: A Randomized, open label study

Vibhay Pareek, R. Bhalavat, M. Chandra, L. Nellore et autres

PO-0180 Impact of hybrid brachytherapy in cervical cancer: A survival and toxicity profile assessment

Vibhay Pareek, Mudit Chandra, R. Bhalavat

PLEN04 Presentation Time: 2:00 PM

Vibhay Pareek, R. Bhalavat, Manish Chandra

in (code pays fourni par la source)

PO-0965: Cardiac dosimetry with or without ABC in left breast cancer irradiation: Single institute experience

Vipul Pareek, R. Bhalavat, M. Chandra, Pratibha Bauskar et autres

Assessment of Impact of Bone Marrow Sparing for Hematological and Gastrointestinal Toxicities in Cervical Cancer with External Beam Radiation Therapy

Ankita Kapoor, R. Bhalavat, Michael Chandra, C. Bakshi et autres

Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines

R. Bhalavat, Ashwini Budrukkar, Sarbani Ghosh Laskar, Dayanand Sharma et autres

PURPOSE: Brachytherapy (BT) forms major treatment modality in squamous cell carcinoma of head and neck cancers (HNC). However, there is a dearth of literature and guidelines for the use in various indications. High-dose-rate brachytherapy (HDR-BT) in Indian scenario is an important treatment …

us, in (code pays fourni par la source)